Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 97 entries
Sorted by: Best Match Show Resources per page
Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients.

Diabetes research and clinical practice

Giorda CB, Forlani G, Manti R, Mazzotti A, De Cosmo S, Rossi MC, Nicolucci A, Di Bartolo P, Ceriello A, Guida P, Tartaglino B, Russo G.
PMID: 29097288
Diabetes Res Clin Pract. 2018 Jan;135:65-72. doi: 10.1016/j.diabres.2017.10.023. Epub 2017 Oct 31.

AIMS: The prevalence and progression of hepatic fibrosis and its correlated factors in type 2 diabetes (T2DM) are poorly known. We aimed to define the percentage of T2DM patients who progress to fibrosis and the factors associated with disease...

Cite
Giorda CB, Forlani G, Manti R, et al. Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients. Diabetes Res Clin Pract. 2017;135:65-72doi: 10.1016/j.diabres.2017.10.023.
Giorda, C. B., Forlani, G., Manti, R., Mazzotti, A., De Cosmo, S., Rossi, M. C., Nicolucci, A., Di Bartolo, P., Ceriello, A., Guida, P., Tartaglino, B., Russo, G. (2018). Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients. Diabetes research and clinical practice, 13565-72. https://doi.org/10.1016/j.diabres.2017.10.023
Giorda, Carlo Bruno, et al. "Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients." Diabetes research and clinical practice vol. 135 (2018): 65-72. doi: https://doi.org/10.1016/j.diabres.2017.10.023
Giorda CB, Forlani G, Manti R, Mazzotti A, De Cosmo S, Rossi MC, Nicolucci A, Di Bartolo P, Ceriello A, Guida P, Tartaglino B, Russo G. Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients. Diabetes Res Clin Pract. 2018 Jan;135:65-72. doi: 10.1016/j.diabres.2017.10.023. Epub 2017 Oct 31. PMID: 29097288.
Copy Download .nbib Format: NLM
Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Simioni N, Filippi A, Scardapane M, Nicolucci A, Rossi MC, Frison V.
PMID: 28585180
Diabetes Ther. 2017 Aug;8(4):941-946. doi: 10.1007/s13300-017-0271-6. Epub 2017 Jun 05.

INTRODUCTION: To assess the efficacy and safety of insulin degludec administered in a basal-bolus regimen according to the GesTIO protocol in noncritical hospitalized patients with T1DM and T2DM.METHODS: Mean blood glucose levels (BG) and their standard deviations (SD) at...

Cite
Simioni N, Filippi A, Scardapane M, et al. Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study. Diabetes Ther. 2017;8(4):941-946doi: 10.1007/s13300-017-0271-6.
Simioni, N., Filippi, A., Scardapane, M., Nicolucci, A., Rossi, M. C., & Frison, V. (2017). Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(4), 941-946. https://doi.org/10.1007/s13300-017-0271-6
Simioni, Natalino, et al. "Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,4 (2017): 941-946. doi: https://doi.org/10.1007/s13300-017-0271-6
Simioni N, Filippi A, Scardapane M, Nicolucci A, Rossi MC, Frison V. Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study. Diabetes Ther. 2017 Aug;8(4):941-946. doi: 10.1007/s13300-017-0271-6. Epub 2017 Jun 05. PMID: 28585180; PMCID: PMC5544608.
Copy Download .nbib Format: NLM
Accounting for "land-grabbing" from a biocapacity viewpoint.

The Science of the total environment

Coscieme L, Pulselli FM, Niccolucci V, Patrizi N, Sutton PC.
PMID: 26383857
Sci Total Environ. 2016 Jan 01;539:551-559. doi: 10.1016/j.scitotenv.2015.09.021. Epub 2015 Sep 16.

The comparison of the Ecological Footprint and its counterpart (i.e. biocapacity) allow for a classification of the world's countries as ecological creditors (Ecological Footprint lower than biocapacity) or debtors (Ecological Footprint higher than biocapacity). This classification is a national...

Cite
Coscieme L, Pulselli FM, Niccolucci V, et al. Accounting for "land-grabbing" from a biocapacity viewpoint. Sci Total Environ. 2015;539:551-559doi: 10.1016/j.scitotenv.2015.09.021.
Coscieme, L., Pulselli, F. M., Niccolucci, V., Patrizi, N., & Sutton, P. C. (2016). Accounting for "land-grabbing" from a biocapacity viewpoint. The Science of the total environment, 539551-559. https://doi.org/10.1016/j.scitotenv.2015.09.021
Coscieme, Luca, et al. "Accounting for "land-grabbing" from a biocapacity viewpoint." The Science of the total environment vol. 539 (2016): 551-559. doi: https://doi.org/10.1016/j.scitotenv.2015.09.021
Coscieme L, Pulselli FM, Niccolucci V, Patrizi N, Sutton PC. Accounting for "land-grabbing" from a biocapacity viewpoint. Sci Total Environ. 2016 Jan 01;539:551-559. doi: 10.1016/j.scitotenv.2015.09.021. Epub 2015 Sep 16. PMID: 26383857.
Copy Download .nbib Format: NLM
The role of peroxiredoxins in cancer.

Molecular and clinical oncology

Nicolussi A, D'Inzeo S, Capalbo C, Giannini G, Coppa A.
PMID: 28357082
Mol Clin Oncol. 2017 Feb;6(2):139-153. doi: 10.3892/mco.2017.1129. Epub 2017 Jan 10.

Peroxiredoxins (PRDXs) are a ubiquitously expressed family of small (22-27 kDa) non-seleno peroxidases that catalyze the peroxide reduction of H

Cite
Nicolussi A, D'Inzeo S, Capalbo C, et al. The role of peroxiredoxins in cancer. Mol Clin Oncol. 2017;6(2):139-153doi: 10.3892/mco.2017.1129.
Nicolussi, A., D'Inzeo, S., Capalbo, C., Giannini, G., & Coppa, A. (2017). The role of peroxiredoxins in cancer. Molecular and clinical oncology, 6(2), 139-153. https://doi.org/10.3892/mco.2017.1129
Nicolussi, Arianna, et al. "The role of peroxiredoxins in cancer." Molecular and clinical oncology vol. 6,2 (2017): 139-153. doi: https://doi.org/10.3892/mco.2017.1129
Nicolussi A, D'Inzeo S, Capalbo C, Giannini G, Coppa A. The role of peroxiredoxins in cancer. Mol Clin Oncol. 2017 Feb;6(2):139-153. doi: 10.3892/mco.2017.1129. Epub 2017 Jan 10. PMID: 28357082; PMCID: PMC5351761.
Copy Download .nbib Format: NLM
Diabetes Attitudes Wishes and Needs 2 (DAWN2): a multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care.

Diabetes research and clinical practice

Peyrot M, Burns KK, Davies M, Forbes A, Hermanns N, Holt R, Kalra S, Nicolucci A, Pouwer F, Wens J, Willaing I, Skovlund SE.
PMID: 23273515
Diabetes Res Clin Pract. 2013 Feb;99(2):174-84. doi: 10.1016/j.diabres.2012.11.016. Epub 2012 Dec 27.

AIMS: The Diabetes Attitudes Wishes and Needs 2 (DAWN2) study aims to provide a holistic assessment of diabetes care and management among people with diabetes (PWD), family members (FM), and healthcare professionals (HCPs) and explores potential drivers leading to...

Cite
Peyrot M, Burns KK, Davies M, et al. Diabetes Attitudes Wishes and Needs 2 (DAWN2): a multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care. Diabetes Res Clin Pract. 2012;99(2):174-84doi: 10.1016/j.diabres.2012.11.016.
Peyrot, M., Burns, K. K., Davies, M., Forbes, A., Hermanns, N., Holt, R., Kalra, S., Nicolucci, A., Pouwer, F., Wens, J., Willaing, I., & Skovlund, S. E. (2013). Diabetes Attitudes Wishes and Needs 2 (DAWN2): a multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care. Diabetes research and clinical practice, 99(2), 174-84. https://doi.org/10.1016/j.diabres.2012.11.016
Peyrot, Mark, et al. "Diabetes Attitudes Wishes and Needs 2 (DAWN2): a multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care." Diabetes research and clinical practice vol. 99,2 (2013): 174-84. doi: https://doi.org/10.1016/j.diabres.2012.11.016
Peyrot M, Burns KK, Davies M, Forbes A, Hermanns N, Holt R, Kalra S, Nicolucci A, Pouwer F, Wens J, Willaing I, Skovlund SE. Diabetes Attitudes Wishes and Needs 2 (DAWN2): a multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care. Diabetes Res Clin Pract. 2013 Feb;99(2):174-84. doi: 10.1016/j.diabres.2012.11.016. Epub 2012 Dec 27. PMID: 23273515.
Copy Download .nbib Format: NLM
Correction: Mobile App-Based Interventions to Support Diabetes Self-Management: A Systematic Review of Randomized Controlled Trials to Identify Functions Associated with Glycemic Efficacy.

JMIR mHealth and uHealth

Wu Y, Yao X, Vespasiani G, Nicolucci A, Dong Y, Kwong J, Li L, Sun X, Tian H, Li S.
PMID: 29334479
JMIR Mhealth Uhealth. 2018 Jan 15;6(1):e20. doi: 10.2196/mhealth.8789.

No abstract available.

Cite
Wu Y, Yao X, Vespasiani G, et al. Correction: Mobile App-Based Interventions to Support Diabetes Self-Management: A Systematic Review of Randomized Controlled Trials to Identify Functions Associated with Glycemic Efficacy. JMIR Mhealth Uhealth. 2018;6(1):e20doi: 10.2196/mhealth.8789.
Wu, Y., Yao, X., Vespasiani, G., Nicolucci, A., Dong, Y., Kwong, J., Li, L., Sun, X., Tian, H., & Li, S. (2018). Correction: Mobile App-Based Interventions to Support Diabetes Self-Management: A Systematic Review of Randomized Controlled Trials to Identify Functions Associated with Glycemic Efficacy. JMIR mHealth and uHealth, 6(1), e20. https://doi.org/10.2196/mhealth.8789
Wu, Yuan, et al. "Correction: Mobile App-Based Interventions to Support Diabetes Self-Management: A Systematic Review of Randomized Controlled Trials to Identify Functions Associated with Glycemic Efficacy." JMIR mHealth and uHealth vol. 6,1 (2018): e20. doi: https://doi.org/10.2196/mhealth.8789
Wu Y, Yao X, Vespasiani G, Nicolucci A, Dong Y, Kwong J, Li L, Sun X, Tian H, Li S. Correction: Mobile App-Based Interventions to Support Diabetes Self-Management: A Systematic Review of Randomized Controlled Trials to Identify Functions Associated with Glycemic Efficacy. JMIR Mhealth Uhealth. 2018 Jan 15;6(1):e20. doi: 10.2196/mhealth.8789. PMID: 29334479; PMCID: PMC5769779.
Copy Download .nbib Format: NLM
Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial.

Acta diabetologica

Musacchio N, Ciullo I, Scardapane M, Giancaterini A, Pessina L, Maino S, Gaiofatto R, Nicolucci A, Rossi MC.
PMID: 29138925
Acta Diabetol. 2018 Mar;55(3):295-299. doi: 10.1007/s00592-017-1072-0. Epub 2017 Nov 14.

No abstract available.

Cite
Musacchio N, Ciullo I, Scardapane M, et al. Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial. Acta Diabetol. 2017;55(3):295-299doi: 10.1007/s00592-017-1072-0.
Musacchio, N., Ciullo, I., Scardapane, M., Giancaterini, A., Pessina, L., Maino, S., Gaiofatto, R., Nicolucci, A., Rossi, M. C. (2018). Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial. Acta diabetologica, 55(3), 295-299. https://doi.org/10.1007/s00592-017-1072-0
Musacchio, Nicoletta, et al. "Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial." Acta diabetologica vol. 55,3 (2018): 295-299. doi: https://doi.org/10.1007/s00592-017-1072-0
Musacchio N, Ciullo I, Scardapane M, Giancaterini A, Pessina L, Maino S, Gaiofatto R, Nicolucci A, Rossi MC. Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial. Acta Diabetol. 2018 Mar;55(3):295-299. doi: 10.1007/s00592-017-1072-0. Epub 2017 Nov 14. PMID: 29138925.
Copy Download .nbib Format: NLM
Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?.

Acta diabetologica

Delvecchio M, Salzano G, Bonura C, Cauvin V, Cherubini V, d'Annunzio G, Franzese A, Giglio S, Grasso V, Graziani V, Iafusco D, Iughetti L, Lera R, Maffeis C, Maltoni G, Mantovani V, Menzaghi C, Patera PI, Rabbone I, Reindstadler P, Scelfo S, Tinto N, Toni S, Tumini S, Lombardo F, Nicolucci A, Barbetti F.
PMID: 29948406
Acta Diabetol. 2018 Sep;55(9):981-983. doi: 10.1007/s00592-018-1179-y. Epub 2018 Jun 13.

No abstract available.

Cite
Delvecchio M, Salzano G, Bonura C, et al. Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?. Acta Diabetol. 2018;55(9):981-983doi: 10.1007/s00592-018-1179-y.
Delvecchio, M., Salzano, G., Bonura, C., Cauvin, V., Cherubini, V., d'Annunzio, G., Franzese, A., Giglio, S., Grasso, V., Graziani, V., Iafusco, D., Iughetti, L., Lera, R., Maffeis, C., Maltoni, G., Mantovani, V., Menzaghi, C., Patera, P. I., Rabbone, I., Reindstadler, P., Scelfo, S., Tinto, N., Toni, S., Tumini, S., Lombardo, F., Nicolucci, A., Barbetti, F. (2018). Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?. Acta diabetologica, 55(9), 981-983. https://doi.org/10.1007/s00592-018-1179-y
Delvecchio, Maurizio, et al. "Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?." Acta diabetologica vol. 55,9 (2018): 981-983. doi: https://doi.org/10.1007/s00592-018-1179-y
Delvecchio M, Salzano G, Bonura C, Cauvin V, Cherubini V, d'Annunzio G, Franzese A, Giglio S, Grasso V, Graziani V, Iafusco D, Iughetti L, Lera R, Maffeis C, Maltoni G, Mantovani V, Menzaghi C, Patera PI, Rabbone I, Reindstadler P, Scelfo S, Tinto N, Toni S, Tumini S, Lombardo F, Nicolucci A, Barbetti F. Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?. Acta Diabetol. 2018 Sep;55(9):981-983. doi: 10.1007/s00592-018-1179-y. Epub 2018 Jun 13. PMID: 29948406.
Copy Download .nbib Format: NLM
Single Low Dose of Cocaine-Structural Brain Injury Without Metabolic and Behavioral Changes.

Frontiers in neuroscience

Nicolucci C, Pais ML, Santos AC, Ribeiro FM, Encarnação PMCC, Silva ALM, Castro IF, Correia PMM, Veloso JFCA, Reis J, Lopes MZ, Botelho MF, Pereira FC, Priolli DG.
PMID: 33584173
Front Neurosci. 2021 Jan 22;14:589897. doi: 10.3389/fnins.2020.589897. eCollection 2020.

Chronic cocaine use has been shown to lead to neurotoxicity in rodents and humans, being associated with high morbidity and mortality rates. However, recreational use, which may lead to addictive behavior, is often neglected. This occurs, in part, due...

Cite
Nicolucci C, Pais ML, Santos AC, et al. Single Low Dose of Cocaine-Structural Brain Injury Without Metabolic and Behavioral Changes. Front Neurosci. 2021;14:589897doi: 10.3389/fnins.2020.589897.
Nicolucci, C., Pais, M. L., Santos, A. C., Ribeiro, F. M., Encarnação, P. M. C. C., Silva, A. L. M., Castro, I. F., Correia, P. M. M., Veloso, J. F. C. A., Reis, J., Lopes, M. Z., Botelho, M. F., Pereira, F. C., & Priolli, D. G. (2020). Single Low Dose of Cocaine-Structural Brain Injury Without Metabolic and Behavioral Changes. Frontiers in neuroscience, 14589897. https://doi.org/10.3389/fnins.2020.589897
Nicolucci, Camilla, et al. "Single Low Dose of Cocaine-Structural Brain Injury Without Metabolic and Behavioral Changes." Frontiers in neuroscience vol. 14 (2020): 589897. doi: https://doi.org/10.3389/fnins.2020.589897
Nicolucci C, Pais ML, Santos AC, Ribeiro FM, Encarnação PMCC, Silva ALM, Castro IF, Correia PMM, Veloso JFCA, Reis J, Lopes MZ, Botelho MF, Pereira FC, Priolli DG. Single Low Dose of Cocaine-Structural Brain Injury Without Metabolic and Behavioral Changes. Front Neurosci. 2021 Jan 22;14:589897. doi: 10.3389/fnins.2020.589897. eCollection 2020. PMID: 33584173; PMCID: PMC7874143.
Copy Download .nbib Format: NLM
Clinical profiles and quality of care of adults with type 1 diabetes according to their cardiovascular Risk: A Multicenter, Observational, retrospective study.

Diabetes research and clinical practice

Pintaudi B, Scatena A, Piscitelli G, Frison V, Corrao S, Manicardi V, Graziano G, Chiara Rossi M, Gallo M, Mannino D, Nicolucci A, Di Bartolo P.
PMID: 34762997
Diabetes Res Clin Pract. 2021 Nov 08;182:109131. doi: 10.1016/j.diabres.2021.109131. Epub 2021 Nov 08.

AIMS: The European Society of Cardiology (ESC) recently defined cardiovascular risk classes for subjects with diabetes. Aim of this study was to explore the distribution of subjects with type 1 diabetes (T1D) by cardiovascular risk groups according to the...

Cite
Pintaudi B, Scatena A, Piscitelli G, et al. Clinical profiles and quality of care of adults with type 1 diabetes according to their cardiovascular Risk: A Multicenter, Observational, retrospective study. Diabetes Res Clin Pract. 2021;182:109131doi: 10.1016/j.diabres.2021.109131.
Pintaudi, B., Scatena, A., Piscitelli, G., Frison, V., Corrao, S., Manicardi, V., Graziano, G., Chiara Rossi, M., Gallo, M., Mannino, D., Nicolucci, A., & Di Bartolo, P. (2021). Clinical profiles and quality of care of adults with type 1 diabetes according to their cardiovascular Risk: A Multicenter, Observational, retrospective study. Diabetes research and clinical practice, 182109131. https://doi.org/10.1016/j.diabres.2021.109131
Pintaudi, Basilio, et al. "Clinical profiles and quality of care of adults with type 1 diabetes according to their cardiovascular Risk: A Multicenter, Observational, retrospective study." Diabetes research and clinical practice vol. 182 (2021): 109131. doi: https://doi.org/10.1016/j.diabres.2021.109131
Pintaudi B, Scatena A, Piscitelli G, Frison V, Corrao S, Manicardi V, Graziano G, Chiara Rossi M, Gallo M, Mannino D, Nicolucci A, Di Bartolo P. Clinical profiles and quality of care of adults with type 1 diabetes according to their cardiovascular Risk: A Multicenter, Observational, retrospective study. Diabetes Res Clin Pract. 2021 Nov 08;182:109131. doi: 10.1016/j.diabres.2021.109131. Epub 2021 Nov 08. PMID: 34762997.
Copy Download .nbib Format: NLM
Adaptation Strategies for Personalized Gait Neuroprosthetics.

Frontiers in neurorobotics

Koelewijn AD, Audu M, Del-Ama AJ, Colucci A, Font-Llagunes JM, Gogeascoechea A, Hnat SK, Makowski N, Moreno JC, Nandor M, Quinn R, Reichenbach M, Reyes RD, Sartori M, Soekadar S, Triolo RJ, Vermehren M, Wenger C, Yavuz US, Fey D, Beckerle P.
PMID: 34975445
Front Neurorobot. 2021 Dec 16;15:750519. doi: 10.3389/fnbot.2021.750519. eCollection 2021.

Personalization of gait neuroprosthetics is paramount to ensure their efficacy for users, who experience severe limitations in mobility without an assistive device. Our goal is to develop assistive devices that collaborate with and are tailored to their users, while...

Cite
Koelewijn AD, Audu M, Del-Ama AJ, et al. Adaptation Strategies for Personalized Gait Neuroprosthetics. Front Neurorobot. 2021;15:750519doi: 10.3389/fnbot.2021.750519.
Koelewijn, A. D., Audu, M., Del-Ama, A. J., Colucci, A., Font-Llagunes, J. M., Gogeascoechea, A., Hnat, S. K., Makowski, N., Moreno, J. C., Nandor, M., Quinn, R., Reichenbach, M., Reyes, R. D., Sartori, M., Soekadar, S., Triolo, R. J., Vermehren, M., Wenger, C., Yavuz, U. S., Fey, D., & Beckerle, P. (2021). Adaptation Strategies for Personalized Gait Neuroprosthetics. Frontiers in neurorobotics, 15750519. https://doi.org/10.3389/fnbot.2021.750519
Koelewijn, Anne D, et al. "Adaptation Strategies for Personalized Gait Neuroprosthetics." Frontiers in neurorobotics vol. 15 (2021): 750519. doi: https://doi.org/10.3389/fnbot.2021.750519
Koelewijn AD, Audu M, Del-Ama AJ, Colucci A, Font-Llagunes JM, Gogeascoechea A, Hnat SK, Makowski N, Moreno JC, Nandor M, Quinn R, Reichenbach M, Reyes RD, Sartori M, Soekadar S, Triolo RJ, Vermehren M, Wenger C, Yavuz US, Fey D, Beckerle P. Adaptation Strategies for Personalized Gait Neuroprosthetics. Front Neurorobot. 2021 Dec 16;15:750519. doi: 10.3389/fnbot.2021.750519. eCollection 2021. PMID: 34975445; PMCID: PMC8716811.
Copy Download .nbib Format: NLM
Design and rationale of DISCOVER global registry in type 2 diabetes: Real-world insights of treatment patterns and its relationship with cardiovascular, renal, and metabolic multimorbidities.

Journal of diabetes and its complications

Khunti K, Heerspink HJL, Lam CSP, Nicolucci A, Ramirez L, Surmont F, Fenici P, Kosiborod M.
PMID: 34686406
J Diabetes Complications. 2021 Dec;35(12):108077. doi: 10.1016/j.jdiacomp.2021.108077. Epub 2021 Oct 13.

AIM: The DISCOVER Global Registry (DGR) aims to provide insights into patient attributes and treatment patterns in patients with type 2 diabetes mellitus (T2DM) seen in clinical practice and understand the patterns and impact of treatment strategies on cardio-renal-metabolic...

Cite
Khunti K, Heerspink HJL, Lam CSP, et al. Design and rationale of DISCOVER global registry in type 2 diabetes: Real-world insights of treatment patterns and its relationship with cardiovascular, renal, and metabolic multimorbidities. J Diabetes Complications. 2021;35(12):108077doi: 10.1016/j.jdiacomp.2021.108077.
Khunti, K., Heerspink, H. J. L., Lam, C. S. P., Nicolucci, A., Ramirez, L., Surmont, F., Fenici, P., & Kosiborod, M. (2021). Design and rationale of DISCOVER global registry in type 2 diabetes: Real-world insights of treatment patterns and its relationship with cardiovascular, renal, and metabolic multimorbidities. Journal of diabetes and its complications, 35(12), 108077. https://doi.org/10.1016/j.jdiacomp.2021.108077
Khunti, Kamlesh, et al. "Design and rationale of DISCOVER global registry in type 2 diabetes: Real-world insights of treatment patterns and its relationship with cardiovascular, renal, and metabolic multimorbidities." Journal of diabetes and its complications vol. 35,12 (2021): 108077. doi: https://doi.org/10.1016/j.jdiacomp.2021.108077
Khunti K, Heerspink HJL, Lam CSP, Nicolucci A, Ramirez L, Surmont F, Fenici P, Kosiborod M. Design and rationale of DISCOVER global registry in type 2 diabetes: Real-world insights of treatment patterns and its relationship with cardiovascular, renal, and metabolic multimorbidities. J Diabetes Complications. 2021 Dec;35(12):108077. doi: 10.1016/j.jdiacomp.2021.108077. Epub 2021 Oct 13. PMID: 34686406.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 97 entries